Furthermore, GITR expression on intratumoral CD4+ T cells was highest in mice receiving GITRL-Fc, suggesting a feedback loop in the GITR expression/pathway activation in syngeneic gliomas (Fig. 6B). The gene discussed is CD4; the disease is central nervous system cancer.